跳至主要内容
临床试验/NCT05601960
NCT05601960已完成不适用

A Combination of a Dermocosmetic and a Tainted Sunscreen Reduce Acne Severity and Signs of Post-inflammatory Hyperpigmentation in Subjects With a Fitzpatrick Phototype Ranging From IV to VI

Cosmetique Active International1 个研究点 分布在 1 个国家目标入组 1,785 人开始时间: 2020年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,785
试验地点
1
主要终点
inflammatory lesions

研究概览

简要总结

Acne is a chronic, inflammatory skin condition. It may cause scars and post-inflammatory hyperpigmentation (PIHP). PIHP frequently affects individuals with a phototype of IV or above.[1] PIHP is worsened by UV radiation, lasts for years and impacts the individual well-being.[2, 3] In an observational study, 1785 adults with a phototype ranging from IV to VI with acne and PIHP applied daily for 2 months a dermocosmetic and a tainted sunscreen product (DC, Effaclar® Duo (+); SS, Anthelios® Shaka Fluide SPF 50+, SS; both La Roche-Posay Laboratoire Dermatologique, France.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • mild to moderate acne
  • presence of postinflammatory hyperpigmentation lesions
  • phototype IV to VI

排除标准

  • less than 18 years
  • severe acne

结局指标

主要结局

inflammatory lesions

时间窗: Month 2

lesion count

PAHPI: post-acne hyperpigmentation index

时间窗: Month 2

post-acne hyperpigmentation index from \<3mm to \>10mm

seborrhoea level

时间窗: Month 2

visual analog scale 0=none to 10= very severe

acne severity

时间窗: Month 2

GEA (Global evaluation of acne) scale 0=none to 5=very severe

non-inflammatory lesions

时间窗: Month 2

lesion count

次要结局

  • Investigator satisfaction acne(Month 2)
  • Investigator satisfaction(Month 2)
  • Patient satisfaction PAHPI(Month 2)
  • Patient: Skin quality(Month 2)
  • Patient satisfaction acne(Month 2)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验